Press Releases

Roswell Park Comprehensive Cancer Center’s Rodney Haring, PhD, MSW, Director of the Center for Indigenous Cancer Research, has been named to the COVID-19 Prevention Network (CoVPN) Native Expert Panel, formed by the National Institute of Allergy and Infectious Disease (NIAID).

Roswell Park Comprehensive Cancer Center, one of the first centers in the world to routinely offer blood and marrow transplants (BMT) and other forms of cellular therapy, has been recognized once more as an Optum^® Center of Excellence in BMT for pediatric and adult patients.

Roswell Park Comprehensive Cancer Center remains the only cancer care facility in Western and Upstate New York to earn a place on U.S. News & World Report’s Best Hospitals list. The Buffalo-based cancer center has retained its no. 14 position among the Best Hospitals for Cancer based on U.S. News’ comprehensive review of numerous indicators of the quality of its care.

Roswell Park Comprehensive Cancer Center and Oneida Health continue to add to the cancer expertise available through their affiliation, announcing the hire of Maya Mathew, MD, as Medical Director of the Dorothy G. Griffin Radiation Oncology Center in Oneida, part of the Roswell Park Care Network.

A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase Clinical Trials and Chief of Melanoma at Roswell Park Comprehensive Cancer Center and published today in the journal JAMA Oncology provides new insights into an important question: whether BRAF V600E/K mutation status or previous BRAF inhibitor (BRAFi) therapy with or without a MEK inhibitor (MEKi) affects response to pembrolizumab (brand name Keytruda) in patients with advanced melanoma.

Proponents of making high-end health care services more accessible to people in Niagara County had reason to celebrate Thursday in downtown Niagara Falls.

The Tauber Bioinformatics Research Center at University of Haifa and Roswell Park Comprehensive Cancer Center in Buffalo, New York have launched a joint collaboration which will couple the expertise in cancer, genomics and biomedical research at Roswell Park and in bioinformatics at University of Haifa.

Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) — a rare and hard-to-treat cancer.